The CYP2A subfamily

Issues in Toxicology

Volumn , Issue , 2008, Pages 150-177

  Raunio, Hannu ^a   Hakkola, Jukka ^b   Pelkonen, Olavi ^b  

^a Department of Pharmacology and Toxicology ^*  (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897481933     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: 10.1039/9781847558428-00150     Document Type: Article

References (155)

1. C.H. Yun, T. Shimada and F.P. Guengerich, Mol. Pharmacol., 1991, 40, 679.
2. J.S. Miles, A.W. McLaren, L.M. Forrester, M.J. Glancey, M.A. Lang and C.R. Wolf, Biochem. J., 1990, 267, 365.
3. S. Yamano, J. Tatsuno and F.J. Gonzalez, Biochemistry, 1990, 29, 1322.
4. O. Pelkonen, A. Rautio, H. Raunio and M. Pasanen, Toxicology, 2000, 144, 139.
5. F.P. Guengerich, in Cytochrome P450 Structure, Mechanism, and Biochemistry, ed. P. Ortiz de Montellano, Kluwer Academic/Plenum Publishers, New York, 2005, p. 377.
6. X. Ding and L.S. Kaminsky, Annu. Rev. Pharmacol. Toxicol., 2003, 43, 149.
7. H. Wang, K.M. Donley, D.S. Keeney and S.M. Hoffman, Environ. Health. Perspect., 2003, 111, 1835.
8. P. Fernandez-Salguero and F.J. Gonzalez, Pharmacogenetics, 1995, 5, S123.
9. T.K.H. Chang and D.J. Waxman, in Cytochromes P450 Metabolic and Toxicological Aspects, ed. C. Ioannides, CRC Press, Boca Raton, 1996, p. 99.
10. P. Honkakoski and M. Negishi, Drug Metab. Rev., 1997, 29, 977.
11. S.M. Hoffman, D.R. Nelson and D.S. Keeney, Pharmacogenetics, 2001, 11, 687.
12. M.T. Skaanild, Curr. Pharm. Des., 2006, 12, 1421.
13. http://drnelson.utmem.edu/biblioA.html.
14. A.J. Lee, M.X. Cai, P.E. Thomas, A.H. Conney and B.T. Zhu, Endocrinology, 2003, 144, 3382.
15. H. Wang, W. Tan, B. Hao, X. Miao, G. Zhou, F. He and D. Lin, Cancer Res., 2003, 63, 8057.
16. M. Negishi, T. Uno, P. Honkakoski, T. Sueyoshi, T.A. Darden and L.P. Pedersen, Biochimie, 1996, 78, 685.
17. R.L. Lindberg and M. Negishi, Nature, 1989, 339, 632.
18. M. Negishi, T. Uno, T.A. Darden, T. Sueyoshi and L.G. Pedersen, FASEB J., 1996, 10, 683.
19. T. Su and X. Ding, Toxicol. Appl. Pharmacol., 2004, 199, 285.
20. J. Hakkola, M. Pasanen, R. Purkunen, S. Saarikoski, O. Pelkonen, J. Maenpaa, A. Rane and H. Raunio, Biochem. Pharmacol., 1994, 48, 59.
21. R.N. Hines and D.G. McCarver, J. Pharmacol. Exp. Ther., 2002, 300, 355.
22. D. Choudhary, I. Jansson, J.B. Schenkman, M. Sarfarazi and I. Stoilov, Arch. Biochem. Biophys., 2003, 414, 91.
23. S. Imaoka, S. Fujita and Y. Funae, Biochim. Biophys. Acta., 1991, 1097, 187.
24. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui and F.P. Guengerich, J. Pharmacol. Exp. Ther., 1994, 270, 414.
25. M. Pasanen, Z. Rannala, A. Tooming, E.A. Sotaniemi, O. Pelkonen and A. Rautio, Toxicology, 1997, 123, 177.
26. Y. Chen, Y.Q. Liu, T. Su, X. Ren, L. Shi, D. Liu, J. Gu, Q.Y. Zhang and X. Ding, Biochem. Pharmacol., 2003, 66, 1245.
27. H. Schrem, J. Klempnauer and J. Borlak, Pharmacol. Rev., 2002, 54, 129.
28. N. Yokomori, K. Nishio, K. Aida and M. Negishi, J. Steroid. Biochem. Mol. Biol., 1997, 62, 307.
29. R. Jover, R. Bort, M.J. Gomez-Lechon and J.V. Castell, Hepatology, 2001, 33, 668.
30. J. Ulvila, S. Arpiainen, O. Pelkonen, K. Aida, T. Sueyoshi, M. Negishi and J. Hakkola, Biochem. J., 2004, 381, 887.
31. M. Pitarque, C. Rodriguez-Antona, M. Oscarson and M. Ingelman-Sundberg, J. Pharmacol. Exp. Ther., 2005, 313, 814.
32. J. Zhang and X. Ding, J. Biol. Chem., 1998, 273, 23454.
33. G. Ling, C.R. Hauer, R.M. Gronostajski, B.T. Pentecost and X. Ding, J. Biol. Chem., 2004, 279, 27888.
34. T. Su, Q.Y. Zhang, J. Zhang, P. Swiatek and X. Ding, Drug Metab. Dispos., 2002, 30, 548.
35. C.A. Wiwi and D.J. Waxman, Growth Factors, 2004, 22, 79.
36. A. Parkinson, D.R. Mudra, C. Johnson, A. Dwyer and K.M. Carroll, Toxicol. Appl. Pharmacol., 2004, 199, 193.
37. N.A. Pampori and B.H. Shapiro, Endocrinology, 1999, 140, 1245.
38. T. Sueyoshi, N. Yokomori, K.S. Korach and M. Negishi, Mol. Pharmacol., 1999, 56, 473.
39. C.A. Wiwi and D.J. Waxman, J. Biol. Chem., 2005, 280, 3259.
40. A. Rautio, H. Kraul, A. Kojo, E. Salmela and O. Pelkonen, Pharmacogenetics, 1992, 2, 227.
41. N.L. Benowitz, C.N. Lessov-Schlaggar, G.E. Swan and P. Jacob, Clin. Pharmacol Ther., 2006, 79, 480.
42. D.J. Lavery, L. Lopez-Molina, R. Margueron, F. Fleury-Olela, F. Conquet, U. Schibler and C. Bonfils, Mol. Cell. Biol., 1999, 19, 6488.
43. P. Viitala, K. Posti, A. Lindfors, O. Pelkonen and H. Raunio, Biochem. Biophys. Res. Commun., 2001, 280, 761.
44. S. Imaoka, Y. Terano and Y. Funae, Arch. Biochem. Biophys., 1990, 278, 168.
45. M. Bauer, A.C. Hamm, M. Bonaus, A. Jacob, J. Jaekel, H. Schorle, M.J. Pankratz and J.D. Katzenberger, Physiol Genomics., 2004, 17, 230.
46. V. Kobliakov, L. Kulikova, D. Samoilov and M.A. Lang, Mol. Carcinog., 1993, 7, 276.
47. G.M. Kirby, P. Pelkonen, V. Vatanasapt, A.M. Camus, C.P. Wild and M.A. Lang, Mol. Carcinog., 1994, 11, 81.
48. T.A. Richardson, M. Sherman, L. Antonovic, S.S. Kardar, H.W. Strobel, D. Kalman and E.T. Morgan, Drug Metab. Dispos., 2006, 34, 354.
49. S. Satarug, M.A. Lang, P. Yongvanit, P. Sithithaworn, E. Mairiang, P. Mairiang, P. Pelkonen, H. Bartsch and M.R. Haswell-Elkins, Cancer Epidemiol. Biomarkers. Prev., 1996, 5, 795.
50. H. Raunio, R. Juvonen, M. Pasanen, O. Pelkonen, P. Pääkkö and Y. Soini, Hepatology, 1998, 27, 427.
51. M.A. Sipowicz, P. Chomarat, B.A. Diwan, M.A. Anver, Y.C. Awasthi, J.M. Ward JM, J.M. Rice, K.S. Kasprzak, C.P. Wild and L.M. Anderson, Am. J. Pathol., 1997, 151, 933.
52. W.J. Gilmore and G. M Kirby, J. Pharmacol. Exp. Ther., 2004, 308, 600.
53. A. Abu-Bakar, S. Satarug, G.C. Marks, M.A. Lang and M.R. Moore, Toxicol. Lett., 2004, 148, 199.
54. J.M. Maglich, C.M. Stoltz, B. Goodwin, D. Hawkins-Brown, J.T. Moore and S.A. Kliewer, Mol. Pharmacol., 2002, 62, 638.
55. P. Wei, J. Zhang, D.H. Dowhan, Y. Han and D.D. Moore, Pharmacogenomics J., 2002, 2, 117.
56. Y. Cai, T. Konishi, G. Han, K.H. Campwala, S.W. French and Y.J. Wan, Eur. J. Pharm. Sci., 2002, 15, 89.
57. M. Itoh, M. Nakajima, E. Higashi, R. Yoshida, K. Nagata, Y. Yamazoe and T. Yokoi, J. Pharmacol. Exp. Ther., 2006, 319, 693.
58. S. Arpiainen, F. Raffalli-Mathieu, M.A. Lang, O. Pelkonen and J. Hakkola, Mol. Pharmacol., 2005, 67, 1325.
59. K. Kurose, M. Tohkin and M. Fukuhara, Mol Pharmacol., 1999, 55, 279.
60. K. Aida and M. Negishi, Biochemistry, 1991, 30, 8041.
61. O. Geneste, F. Raffalli and M.A. Lang, Biochem. J., 1996, 313, 1029.
62. F. Raffalli-Mathieu, T. Glisovic, Y. Ben-David and M.A. Lang, Mol. Pharmacol., 2002, 61, 795.
63. K. Christian, M. Lang, P. Maurel and F. Raffalli-Mathieu, Mol Pharmacol., 2004, 65, 1405.
64. A.W. Wood and A.H. Conney, Science, 1974, 185, 612.
65. H. Raunio, A. Kojo, R. Juvonen, P. Honkakoski, P. Jarvinen, M.A. Lang, K. Vahakangas, H.V. Gelboin, S.S. Park and O. Pelkonen, Biochem. Pharmacol., 1988, 37, 4141.
66. M.T. Donato, P. Viitala, C. Rodriguez-Antona, A. Lindfors, J.V. Castell, H. Raunio, M.J. Gomez-Lechon and O. Pelkonen, Drug. Metab. Dispos., 2000, 28, 1321.
67. W. Legrum and K.J. Netter, Xenobiotica, 1980, 10, 271.
68. S.A. Mangoura, A. Strack, W. Legrum and K.J. Netter, Naunyn Schmiedebergs Arch. Pharmacol., 1989, 339, 596.
69. P. Arvela, H. Kraul, F. Stenback and O. Pelkonen, Toxicology, 1991, 69, 1.
70. B. Emde, M. Tegtmeier, B. Hahnemann and W. Legrum, Toxicology, 1996, 108, 73.
71. P. Salonpaa, K. Krause, O. Pelkonen and H. Raunio, Naunyn Schmiedebergs Arch. Pharmacol., 1995, 351, 446.
72. R.O. Juvonen, S. Autio and M.A. Lang, Biochem. Pharmacol., 1987, 36, 3993.
73. P. Pellinen, F. Stenback, H. Raunio, O. Pelkonen and M. Pasanen, Eur. J. Pharmacol., 1994, 292, 57.
74. P. Pellinen, F. Stenback, A. Rautio, O. Pelkonen, M. Lang and M. Pasanen, Naunyn Schmiedebergs Arch. Pharmacol., 1993, 348, 435.
75. D.F. Lewis and M. Dickins, Drug Discov. Today, 2002, 7, 918.
76. C. de Graaf, N.P. Vermeulen and K.A. Feenstra, J. Med. Chem., 2005, 48, 2725.
77. C.A. Kemp, J.D. Marechal and M.J. Sutcliffe, Arch. Biochem. Biophys., 2005, 433, 361.
78. D.F.V. Lewis and B.G. Lake, Xenobiotica, 1995, 25, 585.
79. D.F. Lewis and B.G. Lake, Xenobiotica, 2002, 32, 547.
80. D.F. Lewis, B.G. Lake, M. Dickins and P.S. Goldfarb, Toxicol. In Vitro, 2003, 17, 179.
81. D.F. Lewis, Y. Ito and B.G. Lake, Toxicol. In Vitro, 2006, 20, 256.
82. A. Gorokhov, M. Negish, E.F. Johnson, L.C. Pedersen, L. Perera, T.A. Darden and L.G. Pedersen, Biophys. J., 2003, 84, 57.
83. J.R. Jalas, M. Seetharaman, S.S. Hecht and S.E. Murphy, Xenobiotica, 2004, 34, 515.
84. G.R. Stahl and H.D. Holtje, Pharmazie, 2005, 60, 247.
85. D.F. Lewis, Toxicol. In Vitro, 2004, 18, 89.
86. A. Poso, J. Gynther and R. Juvonen, J. Comput. Aided Mol. Des., 2001, 15, 195.
87. A. Asikainen, J. Tarhanen, A. Poso, M. Pasanen, E. Alhava and J.O. Juvonen, Toxicol. In Vitro., 2003, 17, 449.
88. M. Rahnasto, H. Raunio, A. Poso, C. Wittekindt and R.O. Juvonen, J. Med. Chem., 2005, 48, 440.
89. J. Yano, M.H. Hsu, K.J. Griffin, C.D. Stout and E.F. Johnson, Nature Struct. Mol. Biol., 2005, 12, 822.
90. M. Rahnasto, C. Wittekindt, R.O. Juvonen, M. Turpeinen, A. Petsalo, O. Pelkonen, A. Poso, G. Stahl, H.D. Höltje, H. Raunio. Pharmacogen J. 2007, Epub ahead of print.
91. X.Y. He, J. Shen, X.Y. Hu, X. Ding, A.Y. Lu and J.Y. Hong, Arch. Biochem. Biophys., 2004, 427, 143-153.
92. D. Kim D, Z.L. Wu and F.P. Guengerich, J. Biol Chem., 2005, 280, 40319.
93. Z.L. Wu, L.M. Podust and F.P. Guengerich, J. Biol. Chem., 2005, 280, 41090.
94. http://www.cypalleles.ki.se
95. M. Nakajima, T. Fukami, H. Yamanaka, E. Higashi, H. Sakai, R. Yoshida, J.T. Kwon, H.L. McLeod and T. Yokoi, Clin. Pharmacol. Ther., 2006, 80, 282.
96. S.L. Wang, X.Y. He, J. Shen, J.S. Wang and J.Y. Hong, Toxicol. Sci., 2006, 94, 38.
97. S. Rendic, Drug Metab. Rev., 2002, 34, 83.
98. R.L. Walsky and R.S. Obach, Drug Metab. Dispos., 2004, 32, 647.
99. R. Yuan, S. Madani, X.X. Wei, K. Reynolds and S.M. Huang, Drug Metab. Dispos., 2002, 30, 1311.
100. L.B. von Weymarn, Q.Y. Zhang, X. Ding and P.F. Hollenberg, Carcinogenesis, 2005, 26, 621.
101. L.B. von Weymarn, J.A. Chun and P.F. Hollenberg, Carcinogenesis, 2006, 27, 782.
102. L.B. von Weymarn, K.M. Brown and S.E. Murphy, J. Pharm. Exp. Ther., 2006, 316, 295.
103. H. Raunio, A. Rautio, H. Gullsten and O. Pelkonen, Br. J. Clin. Pharmacol., 2001, 52, 357.
104. K. Fujita and T. Kamataki, Drug Metab. Disp., 2001, 29, 983.
105. M. Rahnasto, H. Raunio, A. Poso and R.O. Juvonen, Xenobiotica, 2003, 33, 529.
106. J.M. MacDougall, K. Fandrick, X. Zhang, S.V. Serafin and J.R. Cashman, Chem. Res. Toxicol., 2003, 16, 988.
107. N.L. Benowitz, B. Herrera and P. Jacob, J. Pharmacol. Exp. Ther., 2004, 310, 1208.
108. J. Hukkanen, P. Jacob and N.L. Benowitz, Clin. Pharmacol. Ther., 2006, 80, 522.
109. J.K. Yano, T.T. Denton, M.A. Cerny, X. Zhang, E.F. Johnson and J.R. Cashman, J. Med. Chem., 2006, 49, 6987.
110. Z. Bao, X.Y. He, X. Ding, S. Prabhu and J.Y. Hong, Drug Metab. Dispos., 2005, 33, 258.
111. M. Nakajima, M. Itoh, H. Sakai, T. Fukami, M. Katoh, H. Yamazaki, F.F. Kadlubar, S. Imaoka, Y. Funae and T. Yokoi, Int. J. Cancer, 2006, 19, 2520.
112. X.Y. He, L. Tang, S.L. Wang, Q.S. Cai, J.S. Wang and J.Y. Hong, Int. J. Cancer, 2006, 118, 2665.
113. T. Fukami, M. Nakajima, H. Sakai, M. Katoh, T. Yokoi, Drug Metab. Dispos., 2007, 35, 335.
114. WHO Health Report 2002-Reducing Risks, Promoting Healthy Life. WHO, 2002.
115. N.L. Benowitz. 1996, 36, 597.
116. M. Nakajima, T. Yamamoto, K. Nunoya, T. Yokoi, K. Nagashima, K. Inoue, Y. Funae, N. Shimada, T. Kamataki, Y. Kuroiwa, 1996, 24, 1212.
117. E.S. Messina, R.F. Tyndale and E.M. Sellers, J. Pharmacol. Exp. Ther., 1997, 282, 1608.
118. J. Hukkanen, P. Jacob and N.L. Benowitz, Pharmacol. Rev., 2005, 57, 79.
119. R.F. Tyndale and E.M. Sellers, Drug Metab. Dispos., 2001, 29, 548.
120. C. Xu, S. Goodz, E.M. Sellers and R.F. Tyndale, Adv. Drug Deliv. Rev., 2002, 54, 1245.
121. V. Malaiyandi, E.M. Sellers and R.F. Tyndale, Clin. Pharmacol. Ther., 2005, 77, 145.
122. D. Dempsey, P. Tutka, P. Jacob, F. Allen, K. Schoedel, R.F. Tyndale and N.L. Benowitz, Clin. Pharmacol. Ther., 2004, 76, 64.
123. V. Malaiyandi, S.D. Goodz, E.M. Sellers and R.F. Tyndale, Cancer Epidemiol. Biomarkers Prev., 2006, 15, 1812.
124. E. Johnstone, N. Benowitz, A. Cargill, R. Jacob, L. Hinks, I. Day, M. Murphy and R. Walton, Clin Pharmacol. Ther., 2006, 80, 319.
125. T.P. George and S.S. O'Malley, Trends Pharmacol. Sci., 2004, 25, 42.
126. C. Lerman, R. Tyndale, F. Patterson, E.P. Wileyto, P.G. Shields, A. Pinto and N. Benowitz, Clin. Pharmacol. Ther., 2006, 79, 600.
127. E.M. Sellers, H.L. Kaplan and R.F. Tyndale, Clin. Pharmacol. Ther., 2000, 68, 35.
128. W. Zhang, T. Kilicarslan, R.F. Tyndale and E.M. Sellers, Drug Metab. Dispos., 2001, 29, 897.
129. E.M. Sellers, R.F. Tyndale and L.C. Fernandes, Drug Discovery Today, 2003, 8, 487.
130. E.C.K. Siu, D.B. Wildenauer and R.F. Tyndale, Psychopharmacology, 2006, 184, 401.
131. H. Raunio, N. Pokela, K. Puhakainen, M. Rahnasto, T. Mauriala, S. Auriola, R. Juvonen, Xenobiotica, 2007, 38, 34.
132. J.R. Jalas, S.S. Hecht and S.E. Murphy, Chem. Res. Toxicol., 2005, 18, 95.
133. S.S. Hecht, Nat. Rev. Cancer., 2003, 3, 733.
134. T. Kamataki, K. Fujita, K. Nakayama, Y. Yamazaki, M. Miyamoto and N. Ariyoshi, Drug Metab. Rev., 2002, 34, 667.
135. M.L. Pianezza, E.M. Sellers and R.F. Tyndale, Nature, 1998, 393, 750.
136. M. Miyamoto, Y. Umetsu, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh, N. Nemoto, K. Sato, N. Ariyoshi and T. Kamataki, Biochem Biophys Res Commun., 1999, 261, 658.
137. M. Oscarson, Drug Metab. Dispos., 2001, 29, 91.
138. B. Carter, T. Long and P. Cinciripini, Nicotine Tob. Res., 2004, 6, 221.
139. M. Nakajima, Y. Kuroiwa and T. Yokoi, Drug Metab. Rev., 2002, 34, 865.
140. T. Kamataki, M. Fujieda, K. Kiyotani, S. Iwano and H. Kunitoh, Biochem Biophys Res Commun., 2005, 338, 306.
141. M. Miyazaki, E. Sugawara, T. Yoshimura, H. Yamazaki and T. Kamataki, Mutat. Res., 2005, 581, 165.
142. Z. Topcu, I. Chiba, M. Fujieda, T. Shibata, N. Ariyoshi, H. Yamazaki, F. Sevgican, M. Muthumala, H. Kobayashi and T. Kamataki, Carcinogenesis, 2002, 23, 595.
143. H. Takeuchi, K. Saoo, M. Yokohira, M. Ikeda, H. Maeta, M. Miyazaki, H. Yamazaki, T. Kamataki and K. Imaida, Cancer Res., 2003, 63, 7581.
144. M. Miyazaki, H. Yamazaki, H. Takeuchi, K. Saoo, M. Yokohira, K. Masumura, T. Nohmi, Y. Funae, K. Imaida and T. Kamataki, Carcinogenesis, 2005, 26, 1947.
145. W. Godoy, R.M. Albano, E.G. Moraes, P.R. Pinho, R.A. Nunes, E.H. Saito, C. Higa, I.M. Filho, C.D. Kruel, C.C. Schirmer, R. Gurski, M.A. Lang and L.F. Pinto, Carcinogenesis, 2002, 23, 611.
146. M.A. Morse, J. Lu, G.D. Stoner, S.E. Murphy and L.A. Peterson, J. Toxicol. Environ. Health, 1999, 58, 397.
147. W. Tan, G.F. Chen, D.Y. Xing, C.Y. Song, F.F. Kadlubar and D.X. Lin, Int. J. Cancer, 2001, 95, 96.
148. H. Tsukino, Y. Kuroda, D. Qiu, H. Nakao, H. Imai and T. Katoh, Int. J. Cancer, 2002, 100, 425.
149. C. Sweeney, B.F. Coles, S. Nowell, N.P. Lang and F.F. Kadlubar, Toxicology, 2002, 27, 183.
150. C. Sachse, G. Smith, M.J. Wilkie, J.H. Barrett, R. Waxman, F. Sullivan, D. Forman, D.T. Bishop and C.R. Wolf, Carcinogenesis, 2002, 23, 1839.
151. A.J. Cohen, Food Cosmet. Toxicol, 1979, 17, 277.
152. D. Egan, R. O'Kennedy, E. Moran, D. Cox, E. Prosser and R.D. Thornes, Drug Metab. Rev., 1990, 22, 503.
153. B.G. Lake, Food Chem. Toxicol., 1999, 37, 423.
154. O. Pelkonen, H. Raunio, M. Pasanen, A. Rautio and M.A. Lang, in Coumarins Biology, Applications and Mode of Action, ed. R. O'Kennedy and R.D. Thornes, Wiley, Chichester, 1997, p. 67.
155. S.P. Felter, J.D. Vassallo, B.D. Carlton and G.P. Daston, Food Cosmet. Toxicol., 2006, 44, 462.